1. Home
  2. IVP vs ARTL Comparison

IVP vs ARTL Comparison

Compare IVP & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVP
  • ARTL
  • Stock Information
  • Founded
  • IVP 2020
  • ARTL 2011
  • Country
  • IVP United States
  • ARTL United States
  • Employees
  • IVP N/A
  • ARTL N/A
  • Industry
  • IVP Diversified Commercial Services
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IVP Miscellaneous
  • ARTL Health Care
  • Exchange
  • IVP Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • IVP 3.0M
  • ARTL 3.6M
  • IPO Year
  • IVP 2023
  • ARTL N/A
  • Fundamental
  • Price
  • IVP $1.74
  • ARTL $0.88
  • Analyst Decision
  • IVP
  • ARTL Strong Buy
  • Analyst Count
  • IVP 0
  • ARTL 2
  • Target Price
  • IVP N/A
  • ARTL $5.50
  • AVG Volume (30 Days)
  • IVP 92.7K
  • ARTL 13.9K
  • Earning Date
  • IVP 05-14-2025
  • ARTL 05-12-2025
  • Dividend Yield
  • IVP N/A
  • ARTL N/A
  • EPS Growth
  • IVP N/A
  • ARTL N/A
  • EPS
  • IVP N/A
  • ARTL N/A
  • Revenue
  • IVP $16,592,109.00
  • ARTL N/A
  • Revenue This Year
  • IVP N/A
  • ARTL N/A
  • Revenue Next Year
  • IVP N/A
  • ARTL N/A
  • P/E Ratio
  • IVP N/A
  • ARTL N/A
  • Revenue Growth
  • IVP 6.12
  • ARTL N/A
  • 52 Week Low
  • IVP $1.60
  • ARTL $0.86
  • 52 Week High
  • IVP $401.50
  • ARTL $1.60
  • Technical
  • Relative Strength Index (RSI)
  • IVP 36.63
  • ARTL 34.69
  • Support Level
  • IVP $1.60
  • ARTL $0.91
  • Resistance Level
  • IVP $1.76
  • ARTL $1.04
  • Average True Range (ATR)
  • IVP 0.12
  • ARTL 0.04
  • MACD
  • IVP 0.02
  • ARTL -0.00
  • Stochastic Oscillator
  • IVP 25.00
  • ARTL 13.56

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Share on Social Networks: